Sonoma Pharmaceuticals (SNOA) EPS (Basic) (2010 - 2026)
Sonoma Pharmaceuticals' (SNOA) quarterly EPS (Basic) came in at -$0.35 in Q1 2026, up 44.82% year-on-year from -$0.24 in Q1 2025, and up 27.84% quarter-over-quarter from -$0.48 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) EPS (Basic) (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$0.35 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 44.82% year-over-year to -$0.35 in Q1 2026; TTM through Mar 2026 was -$1.89, a 32.32% increase from a year earlier, with the FY2026 full-year figure at -$1.89, up 32.32% from the prior year.
- EPS (Basic) climbed to -$0.35 in Q1 2026 per SNOA's latest filing, from -$0.48 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.32 in Q3 2025 and bottomed at -$12509.7 in Q4 2022.
- The 5-year median for EPS (Basic) is -$1.47 (2023), against an average of -$2392.0.
- Across the five-year window, EPS (Basic) tumbled 768883.23% in 2022 and jumped 99.99% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$12509.7 in 2022, then jumped by 99.99% to -$1.59 in 2023, then surged by 60.08% to -$0.63 in 2024, then climbed by 24.57% to -$0.48 in 2025, then grew by 27.84% to -$0.35 in 2026.
- Per Business Quant, the three latest SNOA EPS (Basic) figures stand at -$0.35 (Q1 2026), -$0.48 (Q4 2025), and -$0.32 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.32 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.11 |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | -0.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.35 |
| Dec 31, 2025 | -0.48 |
| Sep 30, 2025 | -0.32 |
| Jun 30, 2025 | -0.76 |
| Mar 31, 2025 | -0.63 |
| Dec 31, 2024 | -0.63 |
| Sep 30, 2024 | -0.59 |
| Jun 30, 2024 | -1.34 |
| Mar 31, 2024 | -2.35 |
| Dec 31, 2023 | -1.59 |
| Sep 30, 2023 | -5,751.94 |
| Jun 30, 2023 | -5,740.89 |
| Mar 31, 2023 | -7,694.12 |
| Dec 31, 2022 | -12,509.68 |
| Sep 30, 2022 | -6,561.29 |
| Jun 30, 2022 | -5.72 |
| Sep 30, 2021 | -0.85 |
| Jun 30, 2021 | -10.49 |
| Mar 31, 2021 | -2.28 |
| Dec 31, 2020 | -0.23 |